MetLife Investment Management, LLC - G1 THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 127 filers reported holding G1 THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.45 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$177,908
+16.5%
23,409
+56.5%
0.00%0.0%
Q4 2021$152,731
+14.5%
14,959
+50.5%
0.00%0.0%
Q3 2021$133,395
-61.3%
9,940
-36.7%
0.00%
-66.7%
Q2 2021$344,326
-8.8%
15,6940.0%0.00%
-25.0%
Q1 2021$377,598
+33.7%
15,6940.0%0.00%
+33.3%
Q4 2020$282,335
+55.8%
15,6940.0%0.00%
+50.0%
Q3 2020$181,266
-52.4%
15,6940.0%0.00%
-50.0%
Q2 2020$380,736
+120.1%
15,6940.0%0.00%
+100.0%
Q1 2020$172,948
-58.3%
15,6940.0%0.00%
-50.0%
Q4 2019$414,792
+16.0%
15,6940.0%0.00%0.0%
Q3 2019$357,509
-25.7%
15,6940.0%0.00%
-20.0%
Q2 2019$481,174
+200.2%
15,694
+62.5%
0.01%
+150.0%
Q1 2019$160,273
-13.3%
9,6550.0%0.00%0.0%
Q4 2018$184,893
-63.4%
9,6550.0%0.00%
-60.0%
Q3 2018$504,860
+20.2%
9,6550.0%0.01%0.0%
Q2 2018$420,000
+73.6%
9,655
+47.8%
0.01%
+66.7%
Q1 2018$242,000–6,532–0.00%–
 Download
Other shareholders
G1 THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 994,287$19,041,0001.55%
HHLR ADVISORS, LTD. 949,431$18,182,0000.75%
BB BIOTECH AG 671,925$12,867,0000.41%
Rhenman & Partners Asset Management AB 172,820$3,310,0000.38%
Birchview Capital, LP 15,000$287,0000.27%
Rock Springs Capital Management LP 100,000$1,915,0000.09%
SECOR Capital Advisors, LP 32,591$624,0000.08%
MARSHALL WACE, LLP 386,510$7,402,0000.08%
SIGNATUREFD, LLC 37,942$727,0000.07%
A.R.T. Advisors, LLC 38,125$730,0000.05%
View complete list of G1 THERAPEUTICS INC shareholders